NCT00293228View on ClinicalTrials.gov

Treatment of Latent Tuberculosis Infection With Isoniazid

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2009

Conditions
Tuberculosis
Interventions
DRUG

Isoniazid

Isoniazid (5mg per kg up to 300 mg daily for 6 months)

DRUG

isoniazid

isoniazid (5mg per kg up to 300 mg daily for 6 months

Trial Locations (1)

62508

Instituto Nacional de Salud Pública, Cuernavaca

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Wellcome Trust

OTHER

lead

Instituto Nacional de Salud Publica, Mexico

OTHER

NCT00293228 - Treatment of Latent Tuberculosis Infection With Isoniazid | Biotech Hunter | Biotech Hunter